Connor, Clark & Lunn Investment Management (CC&L)’s Axonics, Inc. Common Stock AXNX Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-33,529	Closed	-$2.09M	–	1739
2023 Q4	$2.09M	Sell	33,529 -33,923	-50%	-$1.9M	0.01%	658
2023 Q3	$3.79M	Sell	67,452 -14,504	-18%	-$816K	0.02%	460
2023 Q2	$4.14M	Buy	81,956 +19,101	+30%	+$1.02M	0.02%	437
2023 Q1	$3.43M	Buy	62,855 +1,839	+3%	+$107K	0.02%	442
2022 Q4	$3.82M	Buy	61,016 +25,596	+72%	+$1.7M	0.02%	408
2022 Q3	$2.5M	Buy	35,420 +26,859	+314%	+$1.85M	0.02%	445
2022 Q2	$485K	Buy	+8,561	New	+$469K	﹤0.01%	788

Other funds holding AXNX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s AXNX Position: Q1 2024 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2024, closing a stake of 33,529 shares — an estimated $2.09M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in AXNX in Q2 2022 and held it in 7 quarters. The position peaked at $4.14M in Q2 2023. 235 funds tracked by Wall St. Rank hold AXNX as of Q1 2024.

Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Axonics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Connor, Clark & Lunn Investment Management (CC&L) sold 33,529 Axonics, Inc. Common Stock shares in Q1 2024, an estimated $2.09M.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Axonics, Inc. Common Stock in Q2 2022 and held it in 7 quarters.
Connor, Clark & Lunn Investment Management (CC&L)'s Axonics, Inc. Common Stock position peaked at $4.14M in Q2 2023.
235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2024.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2024, filed 9 May 2024.